518 related articles for article (PubMed ID: 29701271)
1. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
Chang JY; Almazar AE; Richard Locke G; Larson JJ; Atkinson EJ; Talley NJ; Saito YA
Neurogastroenterol Motil; 2018 Sep; 30(9):e13356. PubMed ID: 29701271
[TBL] [Abstract][Full Text] [Related]
2. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.
Vandvik PO; Aabakken L; Farup PG
Scand J Gastroenterol; 2004 May; 39(5):448-53. PubMed ID: 15180182
[TBL] [Abstract][Full Text] [Related]
4. Splitting irritable bowel syndrome: from original Rome to Rome II criteria.
Mearin F; Roset M; Badía X; Balboa A; Baró E; Ponce J; Díaz-Rubio M; Caldwell E; Cucala M; Fueyo A; Talley NJ
Am J Gastroenterol; 2004 Jan; 99(1):122-30. PubMed ID: 14687153
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
[TBL] [Abstract][Full Text] [Related]
6. How individuals with the irritable bowel syndrome describe their own symptoms before formal diagnosis.
Molinder H; Agréus L; Kjellström L; Walter S; Talley NJ; Andreasson A; Nyhlin H
Ups J Med Sci; 2015; 120(4):276-9. PubMed ID: 25947550
[TBL] [Abstract][Full Text] [Related]
7. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
[TBL] [Abstract][Full Text] [Related]
8. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
Aziz I; Törnblom H; Palsson OS; Whitehead WE; Simrén M
Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
[TBL] [Abstract][Full Text] [Related]
9. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
[TBL] [Abstract][Full Text] [Related]
10. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
[TBL] [Abstract][Full Text] [Related]
11. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study.
Goodoory VC; Craig OF; Gracie DJ; Black CJ; Ford AC
Neurogastroenterol Motil; 2022 Jun; 34(6):e14282. PubMed ID: 34612560
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
Black CJ; Yiannakou Y; Houghton LA; Ford AC
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
[TBL] [Abstract][Full Text] [Related]
15. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
[TBL] [Abstract][Full Text] [Related]
17. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
Black CJ; Houghton LA; Ford AC
Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
[TBL] [Abstract][Full Text] [Related]
18. A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care.
Khasawneh M; Craig OF; Gracie DJ; Black CJ; Ford AC
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3397-3404.e1. PubMed ID: 37302448
[TBL] [Abstract][Full Text] [Related]
19. Undiagnosed Celiac Disease In Patients Presenting With Irritable Bowel Syndrome Symptoms.
Khayyat YM
J Ayub Med Coll Abbottabad; 2020; 32(1):18-23. PubMed ID: 32468748
[TBL] [Abstract][Full Text] [Related]
20. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
